GlobeNewswire by notified

Auriant Mining AB (publ.) publishes Q1 2022 operational update

Share

Highlights:

  • In Q1 2022, hard rock gold production amounted to 216.7 kg (6,967 oz), compared to 209.7 kg (6,743 oz) in Q1 2021, an increase of 3%, or 7 kg (224 oz);
  • Due to the seasonality of the operations at Staroverinskaya (Solcocon), there was no alluvial gold production in the period, although 47 155 m3 of top soil was moved in Q1 2022 preparing access to the gold sands;
  • In Q1 2022, total gold sales were 292.1 kg (9,392 oz), compared to 180.0 kg (5,787 oz) in 3m 2021, an increase of 112.1 kg (3,605 oz), or 62%;
  • 96,268 tonnes of ore with an average grade of 2.44 g/t were processed through the CIL plant;
  • The CIL plant operated for 1,887 hours at an increased throughput rate of 51 tonnes per working hour (>50 t/hour) and at the targeted recovery rate of 91.2%;
  • 51,090 tonnes of ore were mined in Q1 2022, compared to 26,190 tonnes in Q1 2021, an increase of 24,900 tonnes or 95%. Stripping volume amounted to 528,200 m3 (+115,600 m3, or 28% more than in Q1 2021);
  • The average grade in Q1 2022 was 2.44 g/t, compared to 2.04 g/t in Q1 2021, an increase of 20%;

Overall, Q1 2022 production was in line with the Company’s production plan.

Others:

  • In regards to the current challenging geopolitical situation, although operations at Tardan have been unaffected, the Company has decided to widen its gold sales channels.  
    • Three new sales contracts with refinery plants were signed.
    • The Company’s subsidiary has applied for an export license to be able to sell gold outside Russia.
    • There is an option of selling gold to a new bank under a new sales contract.   

Despite the current restrictions and the challenging market environment, the Company’s subsidiaries continue to sell gold, but with discounts to the LBMA gold price that can be substantial. The effect of these discounts is to some extent mitigated by the strong gold price and the weak Ruble.   

Total Gold Production

Production unit3m 20223m 2021Change
kgozkgozkgoz%
 Hard rock
    Tardan (CIL) 216.7 6,967 209.7 6,743 7.0 224 3%
Alluvial
Staroverinskaya - - - - - - -
 Total gold produced 216.7 6,967 209.7 6,743 7.0 224 3%

Hard Rock Gold Production

 Unit 3m 20223m 2021 Change
 Mining
 Waste stripping  000 m3         528.2             412.6             115.6   28%
 Ore mined  000 tonnes             51.1               26.2               24.9   95%
 Gold in Ore  kg          134.5               63.4               71.2   112%
 Average grade  g/t            2.63               2.42               0.21   9%
 CIL
 Ore processing  000 tonnes            96.3               96.2                  0.0   0%
 Grade  g/t            2.44               2.04               0.40   20%
 Gold in ore processing  kg         235.2             196.5               38.7   20%
 Gold produced CIL  kg         216.7            209.7                  7.0   3%
 Opening WIP (gold)  kg               5.2               27.9  
 Closing WIP (gold)  kg              2.9  
 Recovery  % 91.18% 92.5% -1.4% -1.5%
 Warehouse on Mar 31
 Ore  000 tonnes            86.4               31.3                55.0   176%
 Grade  g/t            2.16               2.30   -           0.14   -6%

For more information, please contact:

Danilo Lange, CEO
Tel: +7 495 109 02 82
E-mail: d.lange@auriant.com

Company name: Auriant Mining AB Short name: AUR
ISIN-code: SE0001337213

Website: www.auriant.com
www.facebook.com/AuriantMining/

Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in the Republic of Tyva, Zabaikalye and the Republic of Khakassia. The company has currently four assets, including two operating mines (Tardan and Alluvial at Staroverinskaya), one early stage exploration asset and one development asset.

Since July 19, 2010, Auriant Mining´s shares are traded on Nasdaq First North Premier Growth Market under the short name AUR. For more information, please visit www.auriant.com. G&W Fondkommission is Certified Adviser to Auriant, for more information please call +46 8 503 000 50, e-mail CA@gwkapital.se or visit www.gwkapital.se.

This information is information that Auriant Mining AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 15.35 CET on April 20th, 2022.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nokia Corporation: Repurchase of own shares on 28.03.202428.3.2024 21:30:00 CET | Press release

Nokia Corporation Stock Exchange Release 28 March 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 28.03.2024 Espoo, Finland – On 28 March 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL467,1243.29CEUX--BATE--AQEU--TQEX--Total467,1243.29 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 202328.3.2024 21:28:47 CET | Press release

Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist Program: Clinical proof-of-concept data for ORX750 in sleep-deprived healthy volunteers planned in 2024 LockBody® Technology Platform: Ongoing Phase 1/2a study of LB101 (PD-L1xCD47)for the treatment of solid tumors BOSTON and LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported recent business highlights and financial results for the fourth quarter and full-year ended December 31, 2023. “This is an exciting and pivotal time for Centessa,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. “We are laser focused on executing the PRESent registrational studies for SerpinPC, a potential first-in-class subcutaneously administered therapy with a differentiated safety profile for individuals with he

Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results28.3.2024 21:05:00 CET | Press release

SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, today announced financial results for the fourth quarter and year ended December 31, 2023. Results highlight strong BioXp® kit sales, expanding gross margin and reduced operating expense. In discussing the results, Todd R. Nelson Ph.D., Founder and CEO of Telesis Bio said, “I’m pleased with our operating execution in a challenging macro environment during 2023. Our company experienced record BioXp kits sales and expanding gross margin against the backdrop of significant cost cutting initiatives undertaken to align our operating structure with our strategic vision for growth. We believe that our rapid and flexible mRNA synthesis kits are game-changing and unlock tremendous value by providing customers control over their screening and d

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings28.3.2024 21:01:00 CET | Press release

Publication of annual report for financial year 2023Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board membersExtraordinary Shareholders’ Meeting resolutions include approval of renewal of authorized capital and issuance of Gilead Subsequent Warrant B Mechelen, Belgium; 28 March 2024, 21.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2023 and announces its Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) to be held sequentially on Tuesday, 30 April 2024 at 2:00 pm (CET) and 3:00 pm (CET), respectively, at the registered office of the Company. The annual report for the financial year 2023, including a review of figures and performance, is available online at https://www.glpg.com/financial-reports and can also be downloaded as PDF. Our annual 2023 Form 20-F filing with the SEC is available at www.sec.gov/edgar. Galapagos has the

McWhorter Foundation Preparing Legal Battle Against J.P. Morgan Over IPO Discrimination and LBO Biases28.3.2024 19:28:47 CET | Press release

PALM BEACH, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- McWhorter Foundation is poised to launch a groundbreaking legal battle against financial giant J.P. Morgan. With a focus on challenging discriminatory practices in leveraged buyouts (LBOs) and initial public offerings (IPOs), The McWhorter Foundation aims to break down barriers and advocate for equal access to capital markets. Exposing Inequities in IPOs: Recent analyses have highlighted disparities in IPO access, with minority-owned businesses facing systemic hurdles in accessing public markets. McWhorter's legal challenge will illuminate these inequities, compelling J.P. Morgan to address its role in perpetuating barriers to entry for underrepresented entrepreneurs. Leveraging Data for Change: Backed by comprehensive data and extensive research, McWhorter's legal team will present compelling evidence of discrimination in J.P. Morgan's IPO practices. By highlighting patterns of exclusion and unequal treatment, McWhorter Foundation s

HiddenA line styled icon from Orion Icon Library.Eye